DSIP

DSIP stands for Delta Sleep-Inducing Peptide, a neuropeptide that has been studied for its effects on sleep regulation and stress hormones. Its mechanism works through modulating the sleep cycle and stress hormones to promote deeper rest - it is not simply a sedative. Rather than forcing sleep through receptor blockade the way traditional sleep medications do, DSIP is thought to work by influencing the body's own sleep regulation systems, including stress-hormone pathways that can interfere with sleep quality. The primary goal is sleep support - deeper sleep, better regulation of the sleep cycle, and improved overnight recovery. Mood is listed as a minor secondary goal. People who tend to use DSIP are those dealing with poor sleep quality, difficulty reaching deep sleep stages, or stress-related disruptions to sleep. Response to DSIP is noted as variable - some people respond more strongly than others, which is normal for compounds that work through neuromodulatory pathways. It is taken by subcutaneous injection before bed, at a dose of 100 to 300 mcg, used nightly as needed rather than on a fixed daily schedule. Cycles are described as as-needed, making it more flexible than compounds requiring continuous use. It stacks well with Epitalon. DSIP is a research compound and the evidence is classified as anecdotal. It is well tolerated with no specific contraindications based on pregnancy or cancer history listed. Exact dosing is set with a licensed provider in the PepDepo network at consult.